93
Views
15
CrossRef citations to date
0
Altmetric
Review

Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma

Pages 519-527 | Published online: 21 Jun 2013

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.